Skip to main content

SUSQUEHANNA INTERNATIONAL GROUP, LLP

Position in SCYX — Scynexis Inc

CIK 1446194 BALA CYNWYD, PA

Position in SCYX

as of Mar 31, 2026 · filed May 15, 2026
Position Value
$25,499
-$6,742 QoQ
Shares Held
3,476
-45.5% QoQ
Ownership
0.035%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
not a current holder
Holding Since
Jun 2020
20 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in SCYX Over Time

Shares Held

Position Value (USD)

Derivatives in SCYX

reported options exposure · as of Sep 30, 2024
CallValue
$17,284
CallShares
1,450
PutValue
$0
PutShares
0

Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.

Position in Drug Manufacturers - Specialty & Generic

Healthcare · as of Jun 30, 2026

SUSQUEHANNA INTERNATIONAL GROUP, LLP holds $269,786,604 across 51 Drug Manufacturers - Specialty & Generic names.

# Ticker Company Shares Value (USD) Open

All Filings in SCYX

Export CSV
34 filing rows on record
Report Date Value (USD) Shares
2026-03-31 $25,499 27,807
2025-12-31 $32,241 51,015
2025-06-30 $39,641 58,728
2025-03-31 $28,959 30,420
2024-09-30 $17,284 11,600
2024-06-30 $36,200 18,100
2024-03-31 $18,963 12,900
2024-03-31 $21,841 14,858
2023-12-31 $137,180 61,516
2023-12-31 $24,307 10,900
2023-09-30 $28,301 12,413
2023-09-30 $81,168 35,600
2023-09-30 $41,040 18,000
2023-06-30 $46,020 15,600
2023-06-30 $57,315 19,429
2023-03-31 $110,700 36,900
2023-03-31 $206,700 68,900
2022-12-31 $48,282 30,950
2022-12-31 $103,896 66,600
2022-09-30 $24,480 10,200
2022-09-30 $107,524 44,802
2022-03-31 $430,882 110,200
2022-03-31 $75,072 19,200
2021-12-31 $375,760 61,600
2021-12-31 $117,730 19,300
2021-09-30 $1,938,210 365,700
2021-09-30 $482,300 91,000
2021-06-30 $883,200 120,000
2021-06-30 $2,553,184 346,900
2021-03-31 $173,886 21,900
2021-03-31 $483,808 60,933
2021-03-31 $659,814 83,100
2020-12-31 $77,265 10,100
2020-06-30 $16,774 22,336